A peptide-drug conjugate that targets the acidic environment of cancer cells may improve the efficacy of immunotherapy
A peptide-drug conjugate that targets the acidic environment of cancer cells enhanced the efficacy of immune checkpoint inhibitors in preclinical cancer models, according to results presented at the AACR-NCI-EORTC Virtual ...
Oct 7, 2021
0
1